Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RARE

Ultragenyx

$42.07

2.24 (5.62%)

10:49
01/04/19
01/04
10:49
01/04/19
10:49
Recommendations
Ultragenyx analyst commentary at Piper Jaffray »

Ultragenyx preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARE

Ultragenyx

$39.83

-1.92 (-4.60%)

08:33
01/04/19
01/04
08:33
01/04/19
08:33
Hot Stocks
Ultragenyx announces safety, efficacy data from cohort of DTX401 study »

Ultragenyx announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$332.75

-1.27 (-0.38%)

, MRT

MedEquities Realty Trust

$6.83

-0.08 (-1.16%)

09:14
01/02/19
01/02
09:14
01/02/19
09:14
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: MedEquities…

TSLA

Tesla

$332.75

-1.27 (-0.38%)

MRT

MedEquities Realty Trust

$6.83

-0.08 (-1.16%)

PRQR

ProQR Therapeutics

$15.73

0.18 (1.16%)

NTGR

Netgear

$51.99

-0.01 (-0.02%)

ARLO

Arlo Technologies

$0.00

(0.00%)

OHI

Omega Healthcare

$35.14

-0.03 (-0.09%)

NVAX

Novavax

$1.84

0.005 (0.27%)

ATVI

Activision Blizzard

$46.60

-0.23 (-0.49%)

RARE

Ultragenyx

$43.47

1.59 (3.80%)

HOLX

Hologic

$40.98

0.54 (1.34%)

LPX

Louisiana-Pacific

$22.22

0.33 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

RARE

Ultragenyx

$43.47

1.59 (3.80%)

07:51
01/02/19
01/02
07:51
01/02/19
07:51
Downgrade
Ultragenyx rating change at Raymond James »

Ultragenyx downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARE

Ultragenyx

06:12
01/02/19
01/02
06:12
01/02/19
06:12
Downgrade
Ultragenyx rating change at Raymond James »

Ultragenyx downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
RARE

Ultragenyx

$50.39

-3.92 (-7.22%)

08:41
12/06/18
12/06
08:41
12/06/18
08:41
Hot Stocks
Ultragenyx, Kyowa Kirin announce Health Canada approval for Crysvita »

Ultragenyx, Kyowa Hakko…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$23.56

0.29 (1.25%)

, SURF

Surface Oncology

$8.10

-0.15 (-1.82%)

07:55
11/27/18
11/27
07:55
11/27/18
07:55
Conference/Events
Piper Jaffray to hold a conference »

30th Annual Healthcare…

BHC

Bausch Health

$23.56

0.29 (1.25%)

SURF

Surface Oncology

$8.10

-0.15 (-1.82%)

ARRY

Array BioPharma

$15.92

0.27 (1.73%)

IMV

IMV Inc

$5.52

(0.00%)

EBS

Emergent BioSolutions

$70.52

-0.87 (-1.22%)

ZYNE

Zynerba

$5.09

-0.09 (-1.74%)

CYTK

Cytokinetics

$7.68

0.44 (6.08%)

TDOC

Teladoc

$58.43

2.64 (4.73%)

CORV

Correvio

$3.42

0.01 (0.29%)

EXEL

Exelixis

$18.78

0.37 (2.01%)

NBRV

Nabriva Therapeutics

$1.94

-0.09 (-4.43%)

RARE

Ultragenyx

$55.58

2.34 (4.40%)

GERN

Geron

$1.53

0.03 (2.00%)

COX

No Longer Trades

$0.00

(0.00%)

CUE

Cue Biopharma

$5.17

-0.12 (-2.27%)

DCPH

Deciphera

$23.98

0.87 (3.76%)

COLL

Collegium Pharmaceutical

$18.98

0.65 (3.55%)

ATRS

Antares Pharma

$3.39

0.03 (0.89%)

RCUS

Arcus Biosciences

$11.24

-0.37 (-3.19%)

MNLO

Menlo Therapeutics

$6.47

0.08 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 29

    Nov

  • 10

    Dec

  • 12

    Dec

  • 14

    Jan

  • 15

    Feb

  • 25

    Feb

BHC

Bausch Health

$23.56

0.29 (1.25%)

, SURF

Surface Oncology

$8.10

-0.15 (-1.82%)

16:27
11/26/18
11/26
16:27
11/26/18
16:27
Conference/Events
Piper Jaffray to hold a conference »

30th Annual Healthcare…

BHC

Bausch Health

$23.56

0.29 (1.25%)

SURF

Surface Oncology

$8.10

-0.15 (-1.82%)

ARRY

Array BioPharma

$15.92

0.27 (1.73%)

IMV

IMV Inc

$5.52

(0.00%)

EBS

Emergent BioSolutions

$70.52

-0.87 (-1.22%)

ZYNE

Zynerba

$5.09

-0.09 (-1.74%)

CYTK

Cytokinetics

$7.68

0.44 (6.08%)

TDOC

Teladoc

$58.43

2.64 (4.73%)

CORV

Correvio

$3.42

0.01 (0.29%)

EXEL

Exelixis

$18.78

0.37 (2.01%)

NBRV

Nabriva Therapeutics

$1.94

-0.09 (-4.43%)

RARE

Ultragenyx

$55.58

2.34 (4.40%)

GERN

Geron

$1.53

0.03 (2.00%)

COX

No Longer Trades

$0.00

(0.00%)

CUE

Cue Biopharma

$5.17

-0.12 (-2.27%)

DCPH

Deciphera

$23.98

0.87 (3.76%)

COLL

Collegium Pharmaceutical

$18.98

0.65 (3.55%)

ATRS

Antares Pharma

$3.39

0.03 (0.89%)

RCUS

Arcus Biosciences

$11.24

-0.37 (-3.19%)

MNLO

Menlo Therapeutics

$6.47

0.08 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 29

    Nov

  • 10

    Dec

  • 12

    Dec

  • 14

    Jan

  • 15

    Feb

  • 25

    Feb

RARE

Ultragenyx

$51.33

2.92 (6.03%)

13:45
11/15/18
11/15
13:45
11/15/18
13:45
Conference/Events
Ultragenyx haqs a conference call hosted by JPMorgan »

JPMorgan Analyst Kasimov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 27

    Nov

RARE

Ultragenyx

$48.41

-0.47 (-0.96%)

08:22
11/15/18
11/15
08:22
11/15/18
08:22
Conference/Events
Ultragenyx haqs a conference call hosted by JPMorgan »

JPMorgan Analyst Kasimov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.